A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer

Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis

(2016) J. Xia et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer

(2016) Mingmei Huangfu et al.   TUMOR BIOLOGY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer

(2015) Shuang Xu et al.   International Journal of Clinical Oncology

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer

(2015) Yingbo Shao et al.   PLoS One

Identification of a panel of complex autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer

(2015) Xiaoxiao Zuo et al.   TUMOR BIOLOGY

Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer

(2015) Leiguang Ye et al.   FEBS Open Bio

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

(2014) Patricia A.J. Muller et al.   CANCER CELL

MYC Degradation

(2014) A. S. Farrell et al.   Cold Spring Harbor Perspectives in Medicine

Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma

(2013) S. Guan et al.   Clinical & Translational Oncology

Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma

(2013) Leiguang Ye et al.   TUMOR BIOLOGY

Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer

(2013) Cong Zhang et al.   TUMOR BIOLOGY

Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas

(2012) LL Cunha et al.   Clinics

Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: A systematic review

(2012) Maria Lina Tornesello et al.   GYNECOLOGIC ONCOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Annexin 1 Induced by Anti-Inflammatory Drugs Binds to NF- B and Inhibits Its Activation: Anticancer Effects In vitro and In vivo

(2010) Z. Zhang et al.   CANCER RESEARCH

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

(2009) Hyo Song Kim et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women

(2009) C. Desmetz et al.   CLINICAL CANCER RESEARCH

Serum autoantibodies as biomarkers for early cancer detection

(2009) Hwee Tong Tan et al.   FEBS Journal

Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera

(2008) Ji Qiu et al.   JOURNAL OF CLINICAL ONCOLOGY